Prostaglandins E2 and F2alpha reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes.

Cyclooxygenase products modulate the expression of nitric oxide synthase (NOS) in certain cell types. We determined the effect of prostaglandins (PG) E2 and F2alpha on exhaled nitric oxide (NO) concentrations measured by chemiluminescence. Inhaled PGE2 and PGF2alpha significantly reduced exhaled NO. After the highest dose of PGE2 (100 micrograms), NO concentrations fell from 6.9 +/- 0.5 ppb to 4.0 +/- 0.8 ppb (p < 0.001), and from 22.9 +/- 2.0 ppb to 12.3 +/- 1. 2 ppb (p < 0.001), whereas after PGF2alpha, it fell from 6.5 +/- 0.6 ppb to 3.0 +/- 0.5 ppb (p < 0.001), and from 26.0 +/- 3.4 ppb to 11. 5 +/- 1.4 ppb (p < 0.001) in normal (n = 7) and asthmatic (n = 8) subjects, respectively. Although the prostaglandins did not change FEV1 in normal subjects, PGE2 caused an increase in asthmatics (from 3.6 +/- 0.3 L to 3.8 +/- 0.4 L, p < 0.05) and PGF2alpha caused a transient reduction in FEV1 from 4.0 +/- 0.2 L to 3.5 +/- 0.2 L (p < 0.05). To further determine the relationship between bronchoconstriction and exhaled NO levels, we examined the effect of inhaled methacholine which did not change exhaled NO concentrations in normal and asthmatic subjects despite a greater than 20% fall in FEV1 in asthmatics. Therefore, PGE2 and PGF2alpha reduce exhaled NO, an effect not related to airway caliber changes but which may result from an inhibition of nitric oxide synthase (NOS), particularly inducible NOS (iNOS).

[1]  D. Yates,et al.  Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients. , 1997, The European respiratory journal.

[2]  D. Yates,et al.  Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. , 1996, American journal of respiratory and critical care medicine.

[3]  K. Chung,et al.  Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. , 1996, American journal of respiratory and critical care medicine.

[4]  M. Mcdaniel,et al.  Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. , 1996, The American journal of physiology.

[5]  R. M. Refini,et al.  Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. , 1996, American journal of respiratory and critical care medicine.

[6]  M. Mcdaniel,et al.  Cytokines and Nitric Oxide in Islet Inflammation and Diabetes , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[7]  D. Yates,et al.  Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. , 1995, American journal of respiratory and critical care medicine.

[8]  M. Yacoub,et al.  Distribution of human i-NANC bronchodilator and nitric oxide-immunoreactive nerves. , 1995, American journal of respiratory cell and molecular biology.

[9]  J. Stamler,et al.  Expired nitric oxide levels during treatment of acute asthma. , 1995, American journal of respiratory and critical care medicine.

[10]  A. Morrison,et al.  Tyrosine kinase activation is necessary for inducible nitric oxide synthase expression by interleukin-1 beta. , 1995, The American journal of physiology.

[11]  M. Currie,et al.  Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. , 1995, The Journal of clinical investigation.

[12]  P. Barnes,et al.  Nitric oxide and asthmatic inflammation. , 1995, Immunology today.

[13]  I. Pavord,et al.  Bronchoprotective role for endogenous prostaglandin E2 , 1995, The Lancet.

[14]  S. Srivastava,et al.  Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Sanna,et al.  Bronchodilator effect of inhaled nitric oxide in healthy men. , 1994, American journal of respiratory and critical care medicine.

[16]  L. Wu,et al.  Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium. , 1994, The Journal of clinical investigation.

[17]  J. Stamler,et al.  Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Polak,et al.  Expression of inducible nitric oxide in human lung epithelial cells. , 1994, Biochemical and biophysical research communications.

[19]  M. Currie,et al.  Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. , 1994, The Journal of clinical investigation.

[20]  I. Adcock,et al.  Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. , 1994, Biochemical and biophysical research communications.

[21]  J. Stamler,et al.  The biology of nitrogen oxides in the airways. , 1994, American journal of respiratory and critical care medicine.

[22]  P. J. Barnes,et al.  Increased nitric oxide in exhaled air of asthmatic patients , 1994, The Lancet.

[23]  F. Murad,et al.  Identification of an endothelial-like type III NO synthase in LLC-PK1 kidney epithelial cells. , 1994, The American journal of physiology.

[24]  P. Howarth,et al.  Induction of nitric oxide synthase in asthma , 1993, The Lancet.

[25]  G. Hedenstierna,et al.  Inhalation of nitric oxide modulates adult human bronchial tone. , 1993, The American review of respiratory disease.

[26]  P. Barnes,et al.  Nitric oxide and lung disease. , 1993, Thorax.

[27]  J. Stamler,et al.  Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. , 1993, American journal of respiratory cell and molecular biology.

[28]  E. Weitzberg,et al.  Increased amount of nitric oxide in exhaled air of asthmatics. , 1993, The European respiratory journal.

[29]  I. Pavord,et al.  Effect of inhaled prostaglandin E2 on allergen-induced asthma. , 1993, The American review of respiratory disease.

[30]  H. Kuo,et al.  The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea-pig airways. , 1992, European journal of pharmacology.

[31]  S Moncada,et al.  Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. , 1991, Biochemical and biophysical research communications.

[32]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[33]  L. Allegra,et al.  Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. , 1977, Respiration; international review of thoracic diseases.

[34]  A. Smith,et al.  Effects of inhaled prostaglandins E1, E2, and F2alpha on the airway resistance of healthy and asthmatic man. , 1975, Clinical science and molecular medicine.